Literature DB >> 22579380

Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques.

Wilko F A R Verbakel1, Ellen van Reij, Ilonka Ladenius-Lischer, Johan P Cuijpers, Ben J Slotman, Suresh Senan.   

Abstract

PURPOSE: In large stage III lung tumors, planning delivery of doses exceeding 60 Gy can be challenging and time consuming. Intensity modulated radiation therapy (IMRT) can improve target coverage but may increase volumes receiving low-dose irradiation. We clinically implemented a novel hybrid IMRT (h-IMRT) technique that allowed plans to be produced quickly, and compared these plans with 4 other techniques. METHODS AND MATERIALS: h-IMRT was used to treat 14 consecutive patients with planning target volumes (PTVs) exceeding 500 cm(3) (average, 779 cm(3)) with concurrent chemo-radiation therapy to 66 Gy. h-IMRT plans consisted of 2 components: an anterior-posterior/posterior-anterior/posterior-anterior (AP-PA-PA) oblique, open-field technique delivering an average dose of 58 Gy, plus a 3-field IMRT component optimized to achieve a final homogeneous dose of 66 Gy. Total lung V(20) and contralateral lung V(5) were kept as low as possible but preferably less than 35% and less than 50%, respectively. All plans were retrospectively replanned using a 5- to 9-field 3-dimensional conformal technique, full RapidArc, 6-field full IMRT, and a hybrid RapidArc (h-RapidArc) technique similar to the h-IMRT.
RESULTS: The h-IMRT, h-RapidArc, and full RapidArc plans could be generated in less than 2 h, with the first 2 plans achieving the lowest V(5) (36%) and V(20) (30%) values together with the smallest hot spots. Both the 3-dimensional conformal and full IMRT plans occasionally led to unacceptable hot spots outside the PTV. Full RapidArc plans were fast and achieved comparable V(20) values but led to slightly higher V(5) values.
CONCLUSIONS: Both h-IMRT and h-RapidArc permitted delivery of 66 Gy to large stage III lung tumors, and both were superior to either full IMRT or RapidArc plans for reducing lung doses. The clinical significance of small increases in V(5) during chemo-radiation therapy delivery are unknown, but the present study suggests that h-IMRT and h-RapidArc are preferable for treatment of large tumors.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22579380     DOI: 10.1016/j.ijrobp.2011.12.059

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.

Authors:  J-Y Lu; L-L Wu; J-Y Zhang; J Zheng; M L-M Cheung; C-C Ma; L-X Xie; B-T Huang
Journal:  Br J Radiol       Date:  2014-12-12       Impact factor: 3.039

2.  Optimizing the flattening filter free beam selection in RapidArc®-based stereotactic body radiotherapy for Stage I lung cancer.

Authors:  J-Y Lu; Z Lin; P-X Lin; B-T Huang
Journal:  Br J Radiol       Date:  2015-07-02       Impact factor: 3.039

3.  Radiotherapy for a second primary lung cancer arising post-pneumonectomy: planning considerations and clinical outcomes.

Authors:  Sashendra Senthi; Cornelis J A Haasbeek; Frank J Lagerwaard; Wilko F Verbakel; Patricia F de Haan; Ben J Slotman; Suresh Senan
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

4.  Clinical Application of a Hybrid RapidArc Radiotherapy Technique for Locally Advanced Lung Cancer.

Authors:  Scott R Silva; Murat Surucu; Jennifer Steber; Matthew M Harkenrider; Mehee Choi
Journal:  Technol Cancer Res Treat       Date:  2016-09-28

5.  Dosimetric Evaluation of a Simple Planning Technique for Improving Intensity-Modulated Radiotherapy for Nasopharyngeal Cancer.

Authors:  Jia-Yang Lu; Michael Lok-Man Cheung; Mei Li; Bao-Tian Huang; Wen-Jia Xie; Liang-Xi Xie
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

6.  Dosimetric accuracy and clinical quality of Acuros XB and AAA dose calculation algorithm for stereotactic and conventional lung volumetric modulated arc therapy plans.

Authors:  Petra S Kroon; Sandra Hol; Marion Essers
Journal:  Radiat Oncol       Date:  2013-06-24       Impact factor: 3.481

7.  Impacts of lung and tumor volumes on lung dosimetry for nonsmall cell lung cancer.

Authors:  Weijie Lei; Jing Jia; Ruifen Cao; Jing Song; Liqin Hu
Journal:  J Appl Clin Med Phys       Date:  2017-06-28       Impact factor: 2.102

8.  Improving target coverage and organ-at-risk sparing in intensity-modulated radiotherapy for cervical oesophageal cancer using a simple optimisation method.

Authors:  Jia-Yang Lu; Michael Lok-Man Cheung; Bao-Tian Huang; Li-Li Wu; Wen-Jia Xie; Zhi-Jian Chen; De-Rui Li; Liang-Xi Xie
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

9.  A simple optimization approach for improving target dose homogeneity in intensity-modulated radiotherapy for sinonasal cancer.

Authors:  Jia-Yang Lu; Ji-Yong Zhang; Mei Li; Michael Lok-Man Cheung; Yang-Kang Li; Jing Zheng; Bao-Tian Huang; Wu-Zhe Zhang
Journal:  Sci Rep       Date:  2015-10-26       Impact factor: 4.379

10.  Dosimetric evaluation of a simple planning method for improving intensity-modulated radiotherapy for stage III lung cancer.

Authors:  Jia-Yang Lu; Zhu Lin; Jing Zheng; Pei-Xian Lin; Michael Lok-Man Cheung; Bao-Tian Huang
Journal:  Sci Rep       Date:  2016-03-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.